Innovative 3D-Printed Patch Developed to Enhance Skin Cancer Treatment

POLICY WIRE — Belfast, UK — Researchers at Queen’s University Belfast have created a dissolvable 3D-printed patch designed to enhance the treatment of skin cancer. The innovative patch is part of ongoing efforts to improve therapeutic methods for one of the most common forms of cancer.

The patch, developed by a team led by researchers at the university, aims to deliver targeted treatment directly to affected areas, potentially reducing side effects and improving patient outcomes. The 3D-printing technology allows for precise customization, ensuring that each patch can be tailored to the specific needs of individual patients.

“This development represents a significant step forward in the treatment of skin cancer,” said Dr. Jane Mitchell, lead researcher on the project. “By utilizing advanced 3D-printing techniques, we can create patches that are not only effective but also comfortable for patients to use.”

The patch dissolves upon contact with the skin, releasing medication in a controlled manner. This method is intended to ensure that the drug is delivered efficiently to the targeted area, minimizing the risk of systemic side effects often associated with traditional treatments.

Skin cancer, particularly melanoma, is a growing concern globally. According to the World Health Organization, the incidence of melanoma has been rising over the past few decades, making advancements in treatment methods crucial. The new patch could offer a less invasive and more effective alternative to current therapies.

The research team is now planning clinical trials to further evaluate the patch’s efficacy and safety. If successful, the technology could be scaled up for broader use, potentially transforming skin cancer treatment protocols worldwide.

For more on recent medical innovations, read about the hereditary angioedema patient who found relief in a clinical trial at Addenbrooke’s Hospital.

Reporting by Policy-Wire (PW)